2025 third_quarter Filing
Q3Income
$50K
Filed
October 20, 2025
Lobbying Activities
Medicare/MedicaidView all
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Contacted:SENATE, HOUSE OF REPRESENTATIVES
Health IssuesView all
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (7)
mr CHRISTOPHER W HATCHER
JEANNE HAGGERTY
Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
ROBERT BUTORA
Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess